Defining emerging roles for NF-κB in antivirus responses: revisiting the interferon-β enhanceosome paradigm.
Immune Cell Development and Host Defense Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States of America. sid.balachandran@fccc.edu
Siddharth
S
Balachandran
Amer A
AA
Beg
D000818:Animals; D004742:Enhancer Elements, Genetic; D005786:Gene Expression Regulation; D007113:Immunity, Innate; D016899:Interferon-beta / Q000096:biosynthesis / Q000235:genetics* / Q000378:metabolism*; D051379:Mice; D008954:Models, Biological; D016328:NF-kappa B / Q000235:genetics / Q000502:physiology*; D051996:Transcription Factor RelA / Q000235:genetics; D015533:Transcriptional Activation; D014777:Virus Diseases / Q000235:genetics / Q000276:immunology* / Q000378:metabolism; D014780:Viruses / Q000276:immunology*
D016328:NF-kappa B; D051996:Transcription Factor RelA; D016899:Interferon-beta